Remove 2020 Remove Data Remove Treatment
article thumbnail

The Changing Landscape of Medical Marijuana in Massachusetts: What Patients Should Know

Canna Care Docs

Contrary to some narratives of decline, recent data reveals a more nuanced pictureone of evolution, resilience, and an urgent need for continued support. While patient enrollment peaked in 2020, current levels remain significantly higher than when recreational cannabis became legal in 2018. decrease from peak enrollment.

article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. times more likely to achieve their treatment goals with medical cannabis. This gives us baseline measurements that we can track over time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ask The Green Nurse: Why Do People Use Medical Cannabis? Top 3 Evidence-Based Reasons to Consider Plant Medicine

The Cannigma

Cannabis is not a universal cure, but for millions, it provides relief when conventional treatments fail. Unlike many conventional treatments, cannabis offers a level of personalization that sets it apart. Beyond the clichés and outdated stereotypes, the real answer lies in the science—and the stories—of healing.

article thumbnail

Study: Adult-Use Legalization Associated with Decline in Youth Treatment Admissions

NORML

The enactment of adult-use cannabis legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions, according to data published in the journal Drug and Alcohol Dependence. Our results indicate that RML in Colorado and Washington was not associated with an increase in treatment admissions.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.

article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.

article thumbnail

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

NORML

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD